azathioprine has been researched along with dimethyl fumarate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bechara, FG; Gambichler, T; Hessam, S; Rüddel, I; Schmitz, L; Stockfleth, E | 1 |
| Benedetti, MD; Calabria, F; Farina, G; Forgione, A; Forlivesi, S; Gajofatto, A; Marangi, A; Marchioretto, F; Rossi, F; Stenta, G; Vianello, M; Vicenzi, V | 1 |
| Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
| Benedetti, MD; Capobussi, M; Castellini, G; Featherstone, R; Filippini, G; Frau, S; Gonzalez-Lorenzo, M; Lucenteforte, E; Perduca, V; Tramacere, I; Virgili, G | 1 |
1 review(s) available for azathioprine and dimethyl fumarate
| Article | Year |
|---|---|
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.
Topics: Adolescent; Adult; Alemtuzumab; Azathioprine; Cladribine; Daclizumab; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunosuppressive Agents; Immunotherapy; Interferon beta-1a; Interferon beta-1b; Male; Multiple Sclerosis; Natalizumab; Network Meta-Analysis; Rituximab; Young Adult | 2023 |
3 other study(ies) available for azathioprine and dimethyl fumarate
| Article | Year |
|---|---|
Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery.
Topics: 5-Methylcytosine; Azathioprine; Carcinoma, Squamous Cell; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Deoxycytidine; Dimethyl Fumarate; Dioxygenases; DNA-Binding Proteins; Epigenesis, Genetic; ErbB Receptors; Female; Humans; Immunosuppressive Agents; Isocitrate Dehydrogenase; Ki-67 Antigen; Male; Middle Aged; Multiple Sclerosis; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Skin; Skin Neoplasms; Skin Physiological Phenomena; Tumor Suppressor Protein p53 | 2018 |
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy.
Topics: Adult; Azathioprine; Dimethyl Fumarate; Drug Prescriptions; Drug Utilization; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunologic Factors; Italy; Male; Medication Adherence; Middle Aged; Multiple Sclerosis; Time Factors | 2020 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |